Neurocrine Biosciences Inc. Share Price Today, Forecast Target, Chat & Where To Buy [NBIX]

Home > Share Prices > Neurocrine Biosciences Inc. share price (NBIX)

Today's Neurocrine Biosciences Inc. share price is 143.21 (as of 16:00 31-Oct-2025) which is a change of 5.17 or 3.75% from the last closing price of 143.21 with 1,325,948 shares traded giving Neurocrine Biosciences Inc. a market capitalisation of 14,285,067,848. The most recent daily high has been 143.47 and daily low 137.07. The Neurocrine Biosciences Inc. share price 52 week high has been 154.61 and the 52 week low 84.23. Based on the most recent Neurocrine Biosciences Inc. share price opening of 143.21, the current Neurocrine Biosciences Inc. EPS (earnings per share) are 4.19 and the PE (price earnings ratio) is 34.19.

Featured Brokers For Buying Neurocrine Biosciences Inc. Shares

It currently costs 143.21 to buy one share in Neurocrine Biosciences Inc. (as of 16:00 31-Oct-2025) which is a change of 5.17 or 3.75% from the last closing price of 138.04. To buy shares in Neurocrine Biosciences Inc. you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Neurocrine Biosciences Inc. A Good Investment?

The below Neurocrine Biosciences Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top